The High Stakes of Pharmacovigilance: Why Specialized Partnership Outperforms the Large CRO Model

Immunomodulatory therapies and emerging drug associations with microscopic colitis: A global pharmacovigilance analysis

Counterfeit anti-rabies vaccine as a neglected issue: a manufacturers’ perspective

Association between ranitidine use and thyroid cancer based on FAERS and VigiAccess databases

Medication-related nephrotic syndrome: a real-world study from 2004 to 2024 based on the Food and Drug Administration Adverse Event Reporting System

Knowledge, attitude, and practice of undergraduate medical students toward pharmacovigilance and adverse drug reaction reporting: A questionnaire-based study

Post-marketing safety concerns with foscarbidopa/foslevodopa: A pharmacovigilance study with disproportionality analysis based on FAERS

Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports

Turning the tide on substandard and falsified medicines – the Medicine Quality, Innovation & Policy Conference, April 2026

How the VMD monitors the safety of animal medicines

Antibiotic Stewardship: Five Tips to Reduce Resistance

When Medicines Harm: A Systems Analysis of the 2022 Paediatric Acute Kidney Injury Epidemic in The Gambia

Disproportionality and Case-Based Evidence for a Possible Association Between Fluoroquinolones and Kounis Syndrome

Pharmacovigilance signal detection of central nervous system demyelinating diseases following human papillomavirus vaccination: data mining and signal analysis based on the VAERS database

Paroxysmal Nocturnal Hemoglobinuria and Vaccination: A Systematic Pharmacovigilance Analysis of 147 Cases

A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study

Integrating pharmacovigilance into quality and regulatory decision making: A systematic review

INTELIGENCIA ARTIFICIAL Y MEDICINA: DIEZ LECCIONES APRENDIDAS (Y OLVIDADAS): 1970-2026

Pharmacovigilance in Ayurveda: Ensuring Safe Use of Traditional Medicines

Prescription safety in elderly cardiology patients: a cross-sectional study

Optimizing cardiac patients safety: Assessing QT interval-prolonging drug alert in electronic prescription in hospitalized patients

Alerta de circulación irregular de fármacos para uso animal

Strengthening Global Drug and Vaccine Safety Through AI-Driven Pharmacovigilance: Myocarditis Signals, mRNA Vaccine AEFIs, and PV Infrastructure Assessment

Aligned MHRA-NICE approval pathway benefits industry over patients

How Advanced Technology Is Reshaping Medication Safety and Pharmacy Practice

Integrating Vadadustat into Pharmaceutical Care for CKD-Related Anemia: Evidence-Based and Pharmacovigilance Perspectives

Dasatinib-Associated Chylothorax: A Scoping Review and Pharmacovigilance Analysis

Drug Recall Systems in Pharmaceutical Regulation: Regulatory Frameworks, Procedures, and Global Perspectives

Connecticut AG’s crackdown leads to major platform halting sales of “research grade” weight loss chemicals to U.S.

Boletín sobre Seguridad de Medicamentos de Uso Humano. Marzo de 2026

ANMAT cancela la autorización de medicamentos con hidroxietil almidón (HEA) y poli(O-2-hydroxietil)-almidón (HEA) para infusión

Commission welcomes political agreement on Critical Medicines Act

AI-Based Automation for Medication Reconciliation: Scoping Review

The First AI Drug Prescriber

The Burden of Inappropriate Polypharmacy: Approaches to Improve Medication Safety

Factors influencing identification capability of adverse drug reactions in children aged 8–18 years based on social cognitive theory

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland